Literature DB >> 24966902

Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.

Tetsuya Shimabuku1, Ayumi Tamanaha1, Bunta Kitamura1, Yasuka Tanabe1, Natsumi Tawata1, Fukino Ikehara1, Kazunari Arakaki2, Takao Kinjo1.   

Abstract

The prevalence of Epstein-Barr virus (EBV) and high-risk human papilloma virus (HPV) infections in patients with oral cancer in Okinawa, southwest islands of Japan, has led to the hypothesis that carcinogenesis is related to EBV and HPV co-infection. To explore the mechanisms of transformation induced by EBV and HPV co-infection, we analyzed the transformation of primary mouse embryonic fibroblasts (MEFs) expressing EBV and HPV-16 genes, alone or in combination. Expression of EBV latent membrane protein-1 (LMP-1) alone or in combination with HPV-16 E6 increased cell proliferation and decreased apoptosis, whereas single expression of EBV nuclear antigen-1 (EBNA-1), or HPV-16 E6 did not. Co-expression of LMP-1 and E6 induced anchorage-independent growth and tumor formation in nude mice, whereas expression of LMP-1 alone did not. Although the singular expression of these viral genes showed increased DNA damage and DNA damage response (DDR), co-expression of LMP-1 and E6 did not induce DDR, which is frequently seen in cancer cells. Furthermore, co-expression of LMP-1 with E6 increased NF-κB signaling, and the knockdown of LMP-1 or E6 in co-expressing cells decreased cell proliferation, anchorage independent growth, and NF-κB activation. These data suggested that expression of individual viral genes is insufficient for inducing transformation and that co-expression of LMP-1 and E6, which is associated with suppression of DDR and increased NF-κB activity, lead to transformation. Our findings demonstrate the synergistic effect by the interaction of oncogenes from different viruses on the transformation of primary MEFs.

Entities:  

Keywords:  E6; LMP-1; NF-κB; co-expression; primary mouse embryonic fibroblast; transformation

Mesh:

Substances:

Year:  2014        PMID: 24966902      PMCID: PMC4069875     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  50 in total

Review 1.  Proliferation, cell cycle and apoptosis in cancer.

Authors:  G I Evan; K H Vousden
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Time-course of spontaneous transformation of CD-1 mouse embryonic fibroblasts.

Authors:  Ottavio Rossi; Ottavia Barbieri; Guido Frosina
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

3.  Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV).

Authors:  Mayumi Higa; Takao Kinjo; Kazuya Kamiyama; Katsuni Chinen; Teruo Iwamasa; Akira Arasaki; Hajime Sunakawa
Journal:  Oral Oncol       Date:  2003-06       Impact factor: 5.337

4.  Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.

Authors:  M Higa; T Kinjo; K Kamiyama; T Iwamasa; T Hamada; K Iyama
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 5.  Death and anti-death: tumour resistance to apoptosis.

Authors:  Frederik H Igney; Peter H Krammer
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

Review 6.  NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.

Authors:  Ritsuro Suzuki
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

7.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.

Authors:  N E Sharpless; N Bardeesy; K H Lee; D Carrasco; D H Castrillon; A J Aguirre; E A Wu; J W Horner; R A DePinho
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

8.  NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.

Authors:  E D Cahir-McFarland; D M Davidson; S L Schauer; J Duong; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

9.  Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

Authors:  G A Parker; R Touitou; M J Allday
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

10.  Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression.

Authors:  Pankaj Trivedi; Kumi Takazawa; Claudia Zompetta; Laura Cuomo; Elena Anastasiadou; Antonino Carbone; Stefania Uccini; Filippo Belardelli; Kenzo Takada; Luigi Frati; Alberto Faggioni
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

View more
  9 in total

Review 1.  Relationship between the prevalence of oral human papillomavirus DNA and periodontal disease (Review).

Authors:  Hideo Shigeishi; Masaru Sugiyama; Kouji Ohta
Journal:  Biomed Rep       Date:  2021-02-26

2.  Comparative Analysis of Non-viral Transfection Methods in Mouse Embryonic Fibroblast Cells.

Authors:  Migi Lee; Kathleen Chea; Rajyalakshmi Pyda; Melissa Chua; Isabel Dominguez
Journal:  J Biomol Tech       Date:  2017-04-29

3.  Human papillomavirus promotes Epstein-Barr virus maintenance and lytic reactivation in immortalized oral keratinocytes.

Authors:  Kathleen R Makielski; Denis Lee; Laurel D Lorenz; Dhananjay M Nawandar; Ya-Fang Chiu; Shannon C Kenney; Paul F Lambert
Journal:  Virology       Date:  2016-05-11       Impact factor: 3.616

4.  EBV and not HPV sensitizes tobacco-associated head and neck cancer cell line FaDu to radiotherapy.

Authors:  Arunkumar Anandharaj; Oleksandr Ekshyyan; Yali Jia; Xiaohua Rong; Lynn Harrison; Runhua Shi; Rona S Scott; Cherie-Ann O Nathan
Journal:  Acta Otolaryngol       Date:  2015-12-04       Impact factor: 1.494

5.  K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.

Authors:  Ayumi Tamanaha-Nakasone; Karina Uehara; Yasuka Tanabe; Haruna Ishikawa; Natsuko Yamakawa; Zensei Toyoda; Kiyoto Kurima; Shinichiro Kina; Masayuki Tsuneki; Yuko Okubo; Sayaka Yamaguchi; Daisuke Utsumi; Kenzo Takahashi; Hirofumi Arakawa; Akira Arasaki; Takao Kinjo
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

Review 6.  How Does Epstein-Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?

Authors:  Yuxi Wen; Huan Xu; Juan Han; Runming Jin; Hongbo Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

7.  Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.

Authors:  Karina Uehara; Yasuka Tanabe; Shintaro Hirota; Saki Higa; Zensei Toyoda; Kiyoto Kurima; Shinichiro Kina; Toshiyuki Nakasone; Akira Arasaki; Takao Kinjo
Journal:  BMC Cancer       Date:  2021-06-10       Impact factor: 4.430

8.  The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation.

Authors:  Masaru Shimada; Akio Yamashita; Manami Saito; Motohide Ichino; Takao Kinjo; Nobuhisa Mizuki; Dennis M Klinman; Kenji Okuda
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

Review 9.  High-Risk Human Papillomavirus and Epstein-Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis.

Authors:  Rancés Blanco; Diego Carrillo-Beltrán; Alejandro H Corvalán; Francisco Aguayo
Journal:  Biology (Basel)       Date:  2021-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.